ESR Statement on the Validation of Imaging Biomarkers

Abstract Medical imaging capable of generating imaging biomarkers, specifically radiology and nuclear medicine image acquisition and analysis processes, differs from frequently used comparators like blood or urine biomarkers. This difference arises from the sample acquisition methodology. While diff...

Full description

Bibliographic Details
Main Author: European Society of Radiology (ESR)
Format: Article
Language:English
Published: SpringerOpen 2020-06-01
Series:Insights into Imaging
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13244-020-00872-9
_version_ 1819296560336338944
author European Society of Radiology (ESR)
author_facet European Society of Radiology (ESR)
author_sort European Society of Radiology (ESR)
collection DOAJ
description Abstract Medical imaging capable of generating imaging biomarkers, specifically radiology and nuclear medicine image acquisition and analysis processes, differs from frequently used comparators like blood or urine biomarkers. This difference arises from the sample acquisition methodology. While different analysis methodologies and equipment provide slightly different results in any analytical domain, unlike blood or urine analysis where the samples are obtained by simple extraction or excretion, in radiology the acquisition of the sample is heterogeneous by design, since complex equipment from different vendors is used. Therefore, with this additional degree of freedom in medical imaging, there is still risk of persistent heterogeneity of image quality through time, due to different technological implementations across vendors and protocols used in different centres. Quantitative imaging biomarkers have yet to demonstrate an impact on clinical practice due to this lack of comprehensive standardisation in terms of technical aspects of image acquisition, analysis algorithms, processes and clinical validation. The aim is establishing a standard methodology based on metrology for the validation of image acquisition and analysis methods used in the extraction of biomarkers and radiomics data. The appropriate implementation of the guidelines herein proposed by radiology departments, research institutes and industry will allow for a significant reduction in inter-vendor & inter-centre variability in imaging biomarkers and determine the measurement error obtained, enabling them to be used in imaging-based criteria for diagnosis, prognosis or treatment response, ultimately improving clinical workflows and patient care. The validation of developed analytical methods must be based on a technical performance validation and clinical validation.
first_indexed 2024-12-24T05:00:03Z
format Article
id doaj.art-cb4a0d6ef5d04f88bd6f98a622fda95d
institution Directory Open Access Journal
issn 1869-4101
language English
last_indexed 2024-12-24T05:00:03Z
publishDate 2020-06-01
publisher SpringerOpen
record_format Article
series Insights into Imaging
spelling doaj.art-cb4a0d6ef5d04f88bd6f98a622fda95d2022-12-21T17:14:14ZengSpringerOpenInsights into Imaging1869-41012020-06-011111510.1186/s13244-020-00872-9ESR Statement on the Validation of Imaging BiomarkersEuropean Society of Radiology (ESR)Abstract Medical imaging capable of generating imaging biomarkers, specifically radiology and nuclear medicine image acquisition and analysis processes, differs from frequently used comparators like blood or urine biomarkers. This difference arises from the sample acquisition methodology. While different analysis methodologies and equipment provide slightly different results in any analytical domain, unlike blood or urine analysis where the samples are obtained by simple extraction or excretion, in radiology the acquisition of the sample is heterogeneous by design, since complex equipment from different vendors is used. Therefore, with this additional degree of freedom in medical imaging, there is still risk of persistent heterogeneity of image quality through time, due to different technological implementations across vendors and protocols used in different centres. Quantitative imaging biomarkers have yet to demonstrate an impact on clinical practice due to this lack of comprehensive standardisation in terms of technical aspects of image acquisition, analysis algorithms, processes and clinical validation. The aim is establishing a standard methodology based on metrology for the validation of image acquisition and analysis methods used in the extraction of biomarkers and radiomics data. The appropriate implementation of the guidelines herein proposed by radiology departments, research institutes and industry will allow for a significant reduction in inter-vendor & inter-centre variability in imaging biomarkers and determine the measurement error obtained, enabling them to be used in imaging-based criteria for diagnosis, prognosis or treatment response, ultimately improving clinical workflows and patient care. The validation of developed analytical methods must be based on a technical performance validation and clinical validation.http://link.springer.com/article/10.1186/s13244-020-00872-9Imaging biomarkersMetrologyValidationAccuracyPrecision
spellingShingle European Society of Radiology (ESR)
ESR Statement on the Validation of Imaging Biomarkers
Insights into Imaging
Imaging biomarkers
Metrology
Validation
Accuracy
Precision
title ESR Statement on the Validation of Imaging Biomarkers
title_full ESR Statement on the Validation of Imaging Biomarkers
title_fullStr ESR Statement on the Validation of Imaging Biomarkers
title_full_unstemmed ESR Statement on the Validation of Imaging Biomarkers
title_short ESR Statement on the Validation of Imaging Biomarkers
title_sort esr statement on the validation of imaging biomarkers
topic Imaging biomarkers
Metrology
Validation
Accuracy
Precision
url http://link.springer.com/article/10.1186/s13244-020-00872-9
work_keys_str_mv AT europeansocietyofradiologyesr esrstatementonthevalidationofimagingbiomarkers